The co-expression of β-hCG and AFP in patients with colorectal adenocarcinoma is an exceptionally rare association, not previously described, and appears to correlate with poor prognosis, increased local invasion, higher metastatic potential, and reduced survival. The gene discussed is AFP; the disease is colorectal adenocarcinoma.